nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP2C9—brain cancer	0.513	1	CbGaD
Terbinafine—CYP2D6—Lomustine—brain cancer	0.0574	0.178	CbGbCtD
Terbinafine—CYP1A2—Carmustine—brain cancer	0.0568	0.176	CbGbCtD
Terbinafine—CYP2D6—Hydroxyurea—brain cancer	0.0435	0.135	CbGbCtD
Terbinafine—CYP3A4—Temozolomide—brain cancer	0.0429	0.133	CbGbCtD
Terbinafine—PTGS1—Etoposide—brain cancer	0.0377	0.117	CbGbCtD
Terbinafine—CYP3A4—Lomustine—brain cancer	0.0365	0.113	CbGbCtD
Terbinafine—CYP2C8—Etoposide—brain cancer	0.0218	0.0675	CbGbCtD
Terbinafine—CYP1A2—Etoposide—brain cancer	0.0168	0.0523	CbGbCtD
Terbinafine—CYP3A4—Etoposide—brain cancer	0.00882	0.0274	CbGbCtD
Terbinafine—CYP11A1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00254	0.0585	CbGpPWpGaD
Terbinafine—CYP11A1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.00176	0.0406	CbGpPWpGaD
Terbinafine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00168	0.0388	CbGpPWpGaD
Terbinafine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00151	0.0349	CbGpPWpGaD
Terbinafine—PTGS1—Prostaglandin Synthesis and Regulation—S100A6—brain cancer	0.00142	0.0326	CbGpPWpGaD
Terbinafine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00138	0.0317	CbGpPWpGaD
Terbinafine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00135	0.0311	CbGpPWpGaD
Terbinafine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00123	0.0283	CbGpPWpGaD
Terbinafine—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00117	0.027	CbGpPWpGaD
Terbinafine—SQLE—telencephalon—brain cancer	0.00115	0.058	CbGeAlD
Terbinafine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00105	0.0242	CbGpPWpGaD
Terbinafine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00105	0.0241	CbGpPWpGaD
Terbinafine—PTGS1—Prostaglandin Synthesis and Regulation—S100A10—brain cancer	0.000981	0.0226	CbGpPWpGaD
Terbinafine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000962	0.0222	CbGpPWpGaD
Terbinafine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000957	0.0221	CbGpPWpGaD
Terbinafine—SQLE—gonad—brain cancer	0.000957	0.0484	CbGeAlD
Terbinafine—SQLE—pituitary gland—brain cancer	0.000933	0.0472	CbGeAlD
Terbinafine—SQLE—medulla oblongata—brain cancer	0.000901	0.0456	CbGeAlD
Terbinafine—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000838	0.0193	CbGpPWpGaD
Terbinafine—CYP11A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000827	0.0191	CbGpPWpGaD
Terbinafine—SQLE—midbrain—brain cancer	0.000823	0.0416	CbGeAlD
Terbinafine—SQLE—spinal cord—brain cancer	0.000803	0.0406	CbGeAlD
Terbinafine—Alopecia—Lomustine—brain cancer	0.000756	0.00748	CcSEcCtD
Terbinafine—PTGS1—ganglion—brain cancer	0.000735	0.0372	CbGeAlD
Terbinafine—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000727	0.0167	CbGpPWpGaD
Terbinafine—SQLE—endocrine gland—brain cancer	0.000723	0.0366	CbGeAlD
Terbinafine—SQLE—head—brain cancer	0.000714	0.0361	CbGeAlD
Terbinafine—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.000707	0.00699	CcSEcCtD
Terbinafine—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000699	0.0161	CbGpPWpGaD
Terbinafine—Hepatic enzyme increased—Temozolomide—brain cancer	0.000691	0.00684	CcSEcCtD
Terbinafine—Infection—Carboplatin—brain cancer	0.00069	0.00683	CcSEcCtD
Terbinafine—Hearing impaired—Temozolomide—brain cancer	0.000687	0.0068	CcSEcCtD
Terbinafine—CYP11A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000679	0.0157	CbGpPWpGaD
Terbinafine—Hepatic failure—Hydroxyurea—brain cancer	0.000676	0.00669	CcSEcCtD
Terbinafine—Eosinophilia—Procarbazine—brain cancer	0.000672	0.00665	CcSEcCtD
Terbinafine—Pancreatitis—Procarbazine—brain cancer	0.000665	0.00658	CcSEcCtD
Terbinafine—SQLE—central nervous system—brain cancer	0.000652	0.033	CbGeAlD
Terbinafine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000649	0.015	CbGpPWpGaD
Terbinafine—Skin exfoliation—Carmustine—brain cancer	0.000646	0.00639	CcSEcCtD
Terbinafine—SQLE—SREBP signalling—SIRT1—brain cancer	0.000645	0.0149	CbGpPWpGaD
Terbinafine—Pancytopenia—Procarbazine—brain cancer	0.000644	0.00637	CcSEcCtD
Terbinafine—SQLE—cerebellum—brain cancer	0.000637	0.0322	CbGeAlD
Terbinafine—Dermatitis bullous—Hydroxyurea—brain cancer	0.000635	0.00629	CcSEcCtD
Terbinafine—Influenza like illness—Temozolomide—brain cancer	0.000635	0.00628	CcSEcCtD
Terbinafine—PTGS1—endothelium—brain cancer	0.000634	0.032	CbGeAlD
Terbinafine—CYP11A1—gonad—brain cancer	0.000627	0.0317	CbGeAlD
Terbinafine—Skin exfoliation—Temozolomide—brain cancer	0.000624	0.00618	CcSEcCtD
Terbinafine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000624	0.0144	CbGpPWpGaD
Terbinafine—Photosensitivity reaction—Procarbazine—brain cancer	0.000619	0.00613	CcSEcCtD
Terbinafine—Infection—Lomustine—brain cancer	0.000604	0.00597	CcSEcCtD
Terbinafine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000597	0.0138	CbGpPWpGaD
Terbinafine—Thrombocytopenia—Lomustine—brain cancer	0.000595	0.00589	CcSEcCtD
Terbinafine—Pain—Carboplatin—brain cancer	0.000594	0.00588	CcSEcCtD
Terbinafine—CYP11A1—medulla oblongata—brain cancer	0.00059	0.0299	CbGeAlD
Terbinafine—Jaundice—Procarbazine—brain cancer	0.000589	0.00583	CcSEcCtD
Terbinafine—PTGS1—blood vessel—brain cancer	0.000584	0.0296	CbGeAlD
Terbinafine—Anorexia—Lomustine—brain cancer	0.000579	0.00573	CcSEcCtD
Terbinafine—Skin discolouration—Etoposide—brain cancer	0.000579	0.00573	CcSEcCtD
Terbinafine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000574	0.0132	CbGpPWpGaD
Terbinafine—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000555	0.0128	CbGpPWpGaD
Terbinafine—Body temperature increased—Carboplatin—brain cancer	0.000549	0.00543	CcSEcCtD
Terbinafine—CYP19A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000548	0.0126	CbGpPWpGaD
Terbinafine—PTGS1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00054	0.0125	CbGpPWpGaD
Terbinafine—Deafness—Temozolomide—brain cancer	0.00053	0.00525	CcSEcCtD
Terbinafine—Decreased appetite—Lomustine—brain cancer	0.000528	0.00523	CcSEcCtD
Terbinafine—Hepatic failure—Temozolomide—brain cancer	0.000528	0.00523	CcSEcCtD
Terbinafine—Nasal congestion—Temozolomide—brain cancer	0.000521	0.00515	CcSEcCtD
Terbinafine—SQLE—brain—brain cancer	0.000517	0.0262	CbGeAlD
Terbinafine—Pancreatitis—Hydroxyurea—brain cancer	0.000515	0.00509	CcSEcCtD
Terbinafine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000505	0.0116	CbGpPWpGaD
Terbinafine—Dermatitis exfoliative—Temozolomide—brain cancer	0.000503	0.00498	CcSEcCtD
Terbinafine—Skin exfoliation—Etoposide—brain cancer	0.000499	0.00494	CcSEcCtD
Terbinafine—Pancytopenia—Hydroxyurea—brain cancer	0.000498	0.00493	CcSEcCtD
Terbinafine—Neutropenia—Hydroxyurea—brain cancer	0.000491	0.00486	CcSEcCtD
Terbinafine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000486	0.0112	CbGpPWpGaD
Terbinafine—Body temperature increased—Lomustine—brain cancer	0.00048	0.00475	CcSEcCtD
Terbinafine—Alopecia—Procarbazine—brain cancer	0.00048	0.00475	CcSEcCtD
Terbinafine—CYP11A1—endocrine gland—brain cancer	0.000474	0.024	CbGeAlD
Terbinafine—Infestation NOS—Hydroxyurea—brain cancer	0.000468	0.00463	CcSEcCtD
Terbinafine—Infestation—Hydroxyurea—brain cancer	0.000468	0.00463	CcSEcCtD
Terbinafine—CYP11A1—head—brain cancer	0.000468	0.0237	CbGeAlD
Terbinafine—CYP2D6—hindbrain—brain cancer	0.000458	0.0232	CbGeAlD
Terbinafine—CYP19A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00045	0.0104	CbGpPWpGaD
Terbinafine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000445	0.0103	CbGpPWpGaD
Terbinafine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000443	0.00438	CcSEcCtD
Terbinafine—Anaemia—Procarbazine—brain cancer	0.000437	0.00432	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000427	0.00423	CcSEcCtD
Terbinafine—CYP11A1—central nervous system—brain cancer	0.000427	0.0216	CbGeAlD
Terbinafine—CYP19A1—Ovarian Infertility Genes—ESR2—brain cancer	0.000424	0.00978	CbGpPWpGaD
Terbinafine—Cough—Procarbazine—brain cancer	0.000412	0.00408	CcSEcCtD
Terbinafine—CYP19A1—gonad—brain cancer	0.000407	0.0206	CbGeAlD
Terbinafine—Pancytopenia—Carmustine—brain cancer	0.000403	0.00399	CcSEcCtD
Terbinafine—Arthralgia—Procarbazine—brain cancer	0.000402	0.00398	CcSEcCtD
Terbinafine—Myalgia—Procarbazine—brain cancer	0.000402	0.00398	CcSEcCtD
Terbinafine—Anxiety—Procarbazine—brain cancer	0.000401	0.00397	CcSEcCtD
Terbinafine—Neutropenia—Carmustine—brain cancer	0.000397	0.00393	CcSEcCtD
Terbinafine—Dry mouth—Procarbazine—brain cancer	0.000393	0.00389	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Etoposide—brain cancer	0.000392	0.00388	CcSEcCtD
Terbinafine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00039	0.00899	CbGpPWpGaD
Terbinafine—Pancytopenia—Temozolomide—brain cancer	0.000389	0.00385	CcSEcCtD
Terbinafine—Confusional state—Procarbazine—brain cancer	0.000389	0.00385	CcSEcCtD
Terbinafine—Vomiting—Lomustine—brain cancer	0.000386	0.00382	CcSEcCtD
Terbinafine—Neutropenia—Temozolomide—brain cancer	0.000383	0.00379	CcSEcCtD
Terbinafine—Infection—Procarbazine—brain cancer	0.000383	0.00379	CcSEcCtD
Terbinafine—Angiopathy—Hydroxyurea—brain cancer	0.000381	0.00377	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Temozolomide—brain cancer	0.000381	0.00377	CcSEcCtD
Terbinafine—PTGS1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000379	0.00873	CbGpPWpGaD
Terbinafine—Thrombocytopenia—Procarbazine—brain cancer	0.000378	0.00374	CcSEcCtD
Terbinafine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000375	0.00865	CbGpPWpGaD
Terbinafine—Photosensitivity reaction—Temozolomide—brain cancer	0.000374	0.0037	CcSEcCtD
Terbinafine—Alopecia—Hydroxyurea—brain cancer	0.000371	0.00367	CcSEcCtD
Terbinafine—Weight decreased—Temozolomide—brain cancer	0.000371	0.00367	CcSEcCtD
Terbinafine—Anorexia—Procarbazine—brain cancer	0.000368	0.00364	CcSEcCtD
Terbinafine—Erythema—Hydroxyurea—brain cancer	0.000366	0.00362	CcSEcCtD
Terbinafine—Infestation NOS—Temozolomide—brain cancer	0.000366	0.00362	CcSEcCtD
Terbinafine—Infestation—Temozolomide—brain cancer	0.000366	0.00362	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000362	0.00359	CcSEcCtD
Terbinafine—Nausea—Lomustine—brain cancer	0.000361	0.00357	CcSEcCtD
Terbinafine—CYP11A1—Biological oxidations—CYP2C9—brain cancer	0.000361	0.00832	CbGpPWpGaD
Terbinafine—CYP11A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000356	0.0082	CbGpPWpGaD
Terbinafine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000351	0.00348	CcSEcCtD
Terbinafine—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000349	0.00805	CbGpPWpGaD
Terbinafine—Paraesthesia—Procarbazine—brain cancer	0.000346	0.00343	CcSEcCtD
Terbinafine—Hepatobiliary disease—Temozolomide—brain cancer	0.000346	0.00342	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000342	0.00338	CcSEcCtD
Terbinafine—Cramp muscle—Etoposide—brain cancer	0.000342	0.00338	CcSEcCtD
Terbinafine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000339	0.00336	CcSEcCtD
Terbinafine—CYP11A1—brain—brain cancer	0.000339	0.0172	CbGeAlD
Terbinafine—Anaemia—Hydroxyurea—brain cancer	0.000338	0.00335	CcSEcCtD
Terbinafine—Hypoaesthesia—Carmustine—brain cancer	0.000338	0.00334	CcSEcCtD
Terbinafine—Decreased appetite—Procarbazine—brain cancer	0.000335	0.00332	CcSEcCtD
Terbinafine—Connective tissue disorder—Carmustine—brain cancer	0.000334	0.0033	CcSEcCtD
Terbinafine—Fatigue—Procarbazine—brain cancer	0.000333	0.00329	CcSEcCtD
Terbinafine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000331	0.00762	CbGpPWpGaD
Terbinafine—Malaise—Hydroxyurea—brain cancer	0.00033	0.00326	CcSEcCtD
Terbinafine—Pain—Procarbazine—brain cancer	0.00033	0.00326	CcSEcCtD
Terbinafine—Hepatitis—Temozolomide—brain cancer	0.000328	0.00325	CcSEcCtD
Terbinafine—Visual impairment—Carmustine—brain cancer	0.000327	0.00324	CcSEcCtD
Terbinafine—Hypoaesthesia—Temozolomide—brain cancer	0.000327	0.00323	CcSEcCtD
Terbinafine—Connective tissue disorder—Temozolomide—brain cancer	0.000323	0.00319	CcSEcCtD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00032	0.00738	CbGpPWpGaD
Terbinafine—Feeling abnormal—Procarbazine—brain cancer	0.000318	0.00315	CcSEcCtD
Terbinafine—Eye disorder—Carmustine—brain cancer	0.000317	0.00314	CcSEcCtD
Terbinafine—Visual impairment—Temozolomide—brain cancer	0.000316	0.00313	CcSEcCtD
Terbinafine—Gastrointestinal pain—Procarbazine—brain cancer	0.000315	0.00312	CcSEcCtD
Terbinafine—Pancytopenia—Etoposide—brain cancer	0.000312	0.00308	CcSEcCtD
Terbinafine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000312	0.00718	CbGpPWpGaD
Terbinafine—Erythema multiforme—Temozolomide—brain cancer	0.00031	0.00307	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000309	0.00306	CcSEcCtD
Terbinafine—CYP19A1—endocrine gland—brain cancer	0.000308	0.0156	CbGeAlD
Terbinafine—Discomfort—Hydroxyurea—brain cancer	0.000308	0.00304	CcSEcCtD
Terbinafine—Neutropenia—Etoposide—brain cancer	0.000307	0.00304	CcSEcCtD
Terbinafine—Eye disorder—Temozolomide—brain cancer	0.000307	0.00304	CcSEcCtD
Terbinafine—Urticaria—Procarbazine—brain cancer	0.000306	0.00303	CcSEcCtD
Terbinafine—Tinnitus—Temozolomide—brain cancer	0.000306	0.00303	CcSEcCtD
Terbinafine—Abdominal pain—Procarbazine—brain cancer	0.000305	0.00302	CcSEcCtD
Terbinafine—Body temperature increased—Procarbazine—brain cancer	0.000305	0.00302	CcSEcCtD
Terbinafine—CYP19A1—head—brain cancer	0.000304	0.0154	CbGeAlD
Terbinafine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000302	0.00696	CbGpPWpGaD
Terbinafine—Alopecia—Carmustine—brain cancer	0.0003	0.00297	CcSEcCtD
Terbinafine—Angiopathy—Temozolomide—brain cancer	0.000298	0.00295	CcSEcCtD
Terbinafine—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000298	0.00686	CbGpPWpGaD
Terbinafine—Mental disorder—Carmustine—brain cancer	0.000298	0.00294	CcSEcCtD
Terbinafine—Infection—Hydroxyurea—brain cancer	0.000297	0.00293	CcSEcCtD
Terbinafine—Immune system disorder—Temozolomide—brain cancer	0.000296	0.00293	CcSEcCtD
Terbinafine—Erythema—Carmustine—brain cancer	0.000296	0.00293	CcSEcCtD
Terbinafine—Nervous system disorder—Hydroxyurea—brain cancer	0.000293	0.0029	CcSEcCtD
Terbinafine—Infestation—Etoposide—brain cancer	0.000293	0.0029	CcSEcCtD
Terbinafine—Infestation NOS—Etoposide—brain cancer	0.000293	0.0029	CcSEcCtD
Terbinafine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000292	0.00289	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00029	0.00287	CcSEcCtD
Terbinafine—Alopecia—Temozolomide—brain cancer	0.00029	0.00287	CcSEcCtD
Terbinafine—Skin disorder—Hydroxyurea—brain cancer	0.00029	0.00287	CcSEcCtD
Terbinafine—Mental disorder—Temozolomide—brain cancer	0.000288	0.00285	CcSEcCtD
Terbinafine—Erythema—Temozolomide—brain cancer	0.000286	0.00283	CcSEcCtD
Terbinafine—Jaundice—Etoposide—brain cancer	0.000285	0.00282	CcSEcCtD
Terbinafine—CYP2C8—pituitary gland—brain cancer	0.000285	0.0144	CbGeAlD
Terbinafine—Anorexia—Hydroxyurea—brain cancer	0.000285	0.00282	CcSEcCtD
Terbinafine—Hypersensitivity—Procarbazine—brain cancer	0.000284	0.00281	CcSEcCtD
Terbinafine—PTGS1—telencephalon—brain cancer	0.000283	0.0143	CbGeAlD
Terbinafine—Dysgeusia—Temozolomide—brain cancer	0.00028	0.00277	CcSEcCtD
Terbinafine—Vision blurred—Carmustine—brain cancer	0.000279	0.00276	CcSEcCtD
Terbinafine—CYP19A1—central nervous system—brain cancer	0.000278	0.014	CbGeAlD
Terbinafine—Asthenia—Procarbazine—brain cancer	0.000277	0.00274	CcSEcCtD
Terbinafine—Hepatobiliary disease—Etoposide—brain cancer	0.000277	0.00274	CcSEcCtD
Terbinafine—Anaemia—Carmustine—brain cancer	0.000273	0.0027	CcSEcCtD
Terbinafine—Agranulocytosis—Etoposide—brain cancer	0.000273	0.0027	CcSEcCtD
Terbinafine—Pruritus—Procarbazine—brain cancer	0.000273	0.0027	CcSEcCtD
Terbinafine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000269	0.00621	CbGpPWpGaD
Terbinafine—Vision blurred—Temozolomide—brain cancer	0.000269	0.00267	CcSEcCtD
Terbinafine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000268	0.00617	CbGpPWpGaD
Terbinafine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000266	0.00613	CbGpPWpGaD
Terbinafine—Ill-defined disorder—Temozolomide—brain cancer	0.000265	0.00262	CcSEcCtD
Terbinafine—Anaemia—Temozolomide—brain cancer	0.000264	0.00261	CcSEcCtD
Terbinafine—Diarrhoea—Procarbazine—brain cancer	0.000264	0.00261	CcSEcCtD
Terbinafine—Dyspepsia—Hydroxyurea—brain cancer	0.000263	0.0026	CcSEcCtD
Terbinafine—CYP2D6—brainstem—brain cancer	0.000263	0.0133	CbGeAlD
Terbinafine—Hypoaesthesia—Etoposide—brain cancer	0.000261	0.00259	CcSEcCtD
Terbinafine—Angioedema—Temozolomide—brain cancer	0.000261	0.00258	CcSEcCtD
Terbinafine—Decreased appetite—Hydroxyurea—brain cancer	0.000259	0.00257	CcSEcCtD
Terbinafine—CYP19A1—Ovarian Infertility Genes—CDK4—brain cancer	0.000258	0.00596	CbGpPWpGaD
Terbinafine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000258	0.00255	CcSEcCtD
Terbinafine—Malaise—Temozolomide—brain cancer	0.000258	0.00255	CcSEcCtD
Terbinafine—Fatigue—Hydroxyurea—brain cancer	0.000257	0.00255	CcSEcCtD
Terbinafine—Vertigo—Temozolomide—brain cancer	0.000257	0.00254	CcSEcCtD
Terbinafine—Pain—Hydroxyurea—brain cancer	0.000255	0.00253	CcSEcCtD
Terbinafine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000255	0.00588	CbGpPWpGaD
Terbinafine—Dizziness—Procarbazine—brain cancer	0.000255	0.00252	CcSEcCtD
Terbinafine—CYP2C19—endocrine gland—brain cancer	0.000253	0.0128	CbGeAlD
Terbinafine—Chest pain—Carmustine—brain cancer	0.000252	0.00249	CcSEcCtD
Terbinafine—Myalgia—Carmustine—brain cancer	0.000252	0.00249	CcSEcCtD
Terbinafine—Anxiety—Carmustine—brain cancer	0.000251	0.00248	CcSEcCtD
Terbinafine—Cough—Temozolomide—brain cancer	0.000249	0.00247	CcSEcCtD
Terbinafine—Erythema multiforme—Etoposide—brain cancer	0.000248	0.00246	CcSEcCtD
Terbinafine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000248	0.00571	CbGpPWpGaD
Terbinafine—Feeling abnormal—Hydroxyurea—brain cancer	0.000246	0.00243	CcSEcCtD
Terbinafine—Eye disorder—Etoposide—brain cancer	0.000245	0.00243	CcSEcCtD
Terbinafine—Vomiting—Procarbazine—brain cancer	0.000245	0.00243	CcSEcCtD
Terbinafine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000245	0.00564	CbGpPWpGaD
Terbinafine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000244	0.00563	CbGpPWpGaD
Terbinafine—Confusional state—Carmustine—brain cancer	0.000243	0.00241	CcSEcCtD
Terbinafine—Myalgia—Temozolomide—brain cancer	0.000243	0.00241	CcSEcCtD
Terbinafine—Arthralgia—Temozolomide—brain cancer	0.000243	0.00241	CcSEcCtD
Terbinafine—Rash—Procarbazine—brain cancer	0.000243	0.00241	CcSEcCtD
Terbinafine—Dermatitis—Procarbazine—brain cancer	0.000243	0.0024	CcSEcCtD
Terbinafine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000243	0.0056	CbGpPWpGaD
Terbinafine—Anxiety—Temozolomide—brain cancer	0.000242	0.0024	CcSEcCtD
Terbinafine—Headache—Procarbazine—brain cancer	0.000242	0.00239	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000242	0.00239	CcSEcCtD
Terbinafine—Discomfort—Temozolomide—brain cancer	0.00024	0.00238	CcSEcCtD
Terbinafine—Infection—Carmustine—brain cancer	0.00024	0.00237	CcSEcCtD
Terbinafine—CYP19A1—Biological oxidations—CYP2C9—brain cancer	0.000239	0.00551	CbGpPWpGaD
Terbinafine—Angiopathy—Etoposide—brain cancer	0.000238	0.00236	CcSEcCtD
Terbinafine—Dry mouth—Temozolomide—brain cancer	0.000238	0.00235	CcSEcCtD
Terbinafine—Immune system disorder—Etoposide—brain cancer	0.000237	0.00235	CcSEcCtD
Terbinafine—Thrombocytopenia—Carmustine—brain cancer	0.000236	0.00234	CcSEcCtD
Terbinafine—Body temperature increased—Hydroxyurea—brain cancer	0.000236	0.00234	CcSEcCtD
Terbinafine—CYP19A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000236	0.00543	CbGpPWpGaD
Terbinafine—Confusional state—Temozolomide—brain cancer	0.000235	0.00233	CcSEcCtD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000234	0.0054	CbGpPWpGaD
Terbinafine—Anaphylactic shock—Temozolomide—brain cancer	0.000233	0.00231	CcSEcCtD
Terbinafine—CYP2D6—telencephalon—brain cancer	0.000233	0.0118	CbGeAlD
Terbinafine—Alopecia—Etoposide—brain cancer	0.000232	0.0023	CcSEcCtD
Terbinafine—Infection—Temozolomide—brain cancer	0.000232	0.00229	CcSEcCtD
Terbinafine—PTGS1—pituitary gland—brain cancer	0.000231	0.0117	CbGeAlD
Terbinafine—Anorexia—Carmustine—brain cancer	0.00023	0.00228	CcSEcCtD
Terbinafine—Nausea—Procarbazine—brain cancer	0.000229	0.00227	CcSEcCtD
Terbinafine—Nervous system disorder—Temozolomide—brain cancer	0.000229	0.00226	CcSEcCtD
Terbinafine—Thrombocytopenia—Temozolomide—brain cancer	0.000228	0.00226	CcSEcCtD
Terbinafine—Skin disorder—Temozolomide—brain cancer	0.000227	0.00224	CcSEcCtD
Terbinafine—Dysgeusia—Etoposide—brain cancer	0.000224	0.00222	CcSEcCtD
Terbinafine—Anorexia—Temozolomide—brain cancer	0.000222	0.0022	CcSEcCtD
Terbinafine—CYP2C8—endocrine gland—brain cancer	0.00022	0.0112	CbGeAlD
Terbinafine—CYP19A1—brain—brain cancer	0.00022	0.0111	CbGeAlD
Terbinafine—Hypersensitivity—Hydroxyurea—brain cancer	0.00022	0.00218	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00022	0.00218	CcSEcCtD
Terbinafine—Muscle spasms—Etoposide—brain cancer	0.00022	0.00218	CcSEcCtD
Terbinafine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000218	0.00503	CbGpPWpGaD
Terbinafine—Paraesthesia—Carmustine—brain cancer	0.000217	0.00214	CcSEcCtD
Terbinafine—Asthenia—Hydroxyurea—brain cancer	0.000214	0.00212	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000212	0.0021	CcSEcCtD
Terbinafine—Ill-defined disorder—Etoposide—brain cancer	0.000212	0.0021	CcSEcCtD
Terbinafine—Anaemia—Etoposide—brain cancer	0.000211	0.00209	CcSEcCtD
Terbinafine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00021	0.00484	CbGpPWpGaD
Terbinafine—Decreased appetite—Carmustine—brain cancer	0.00021	0.00208	CcSEcCtD
Terbinafine—Paraesthesia—Temozolomide—brain cancer	0.000209	0.00207	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Carmustine—brain cancer	0.000208	0.00206	CcSEcCtD
Terbinafine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000207	0.00477	CbGpPWpGaD
Terbinafine—Pain—Carmustine—brain cancer	0.000206	0.00204	CcSEcCtD
Terbinafine—CYP1A2—endocrine gland—brain cancer	0.000206	0.0104	CbGeAlD
Terbinafine—Malaise—Etoposide—brain cancer	0.000206	0.00204	CcSEcCtD
Terbinafine—Vertigo—Etoposide—brain cancer	0.000205	0.00203	CcSEcCtD
Terbinafine—Dyspepsia—Temozolomide—brain cancer	0.000205	0.00203	CcSEcCtD
Terbinafine—Diarrhoea—Hydroxyurea—brain cancer	0.000204	0.00202	CcSEcCtD
Terbinafine—Decreased appetite—Temozolomide—brain cancer	0.000203	0.00201	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000201	0.00199	CcSEcCtD
Terbinafine—PTGS1—Biological oxidations—CYP2C9—brain cancer	0.000201	0.00464	CbGpPWpGaD
Terbinafine—Fatigue—Temozolomide—brain cancer	0.000201	0.00199	CcSEcCtD
Terbinafine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000201	0.00463	CbGpPWpGaD
Terbinafine—Cough—Etoposide—brain cancer	0.0002	0.00197	CcSEcCtD
Terbinafine—Pain—Temozolomide—brain cancer	0.000199	0.00197	CcSEcCtD
Terbinafine—Feeling abnormal—Carmustine—brain cancer	0.000199	0.00197	CcSEcCtD
Terbinafine—PTGS1—spinal cord—brain cancer	0.000199	0.01	CbGeAlD
Terbinafine—Dizziness—Hydroxyurea—brain cancer	0.000197	0.00195	CcSEcCtD
Terbinafine—Gastrointestinal pain—Carmustine—brain cancer	0.000197	0.00195	CcSEcCtD
Terbinafine—CYP2C9—endocrine gland—brain cancer	0.000196	0.00991	CbGeAlD
Terbinafine—Chest pain—Etoposide—brain cancer	0.000195	0.00193	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000193	0.00191	CcSEcCtD
Terbinafine—Discomfort—Etoposide—brain cancer	0.000192	0.0019	CcSEcCtD
Terbinafine—Feeling abnormal—Temozolomide—brain cancer	0.000192	0.0019	CcSEcCtD
Terbinafine—Abdominal pain—Carmustine—brain cancer	0.000191	0.00189	CcSEcCtD
Terbinafine—Body temperature increased—Carmustine—brain cancer	0.000191	0.00189	CcSEcCtD
Terbinafine—Gastrointestinal pain—Temozolomide—brain cancer	0.000191	0.00189	CcSEcCtD
Terbinafine—Vomiting—Hydroxyurea—brain cancer	0.00019	0.00188	CcSEcCtD
Terbinafine—Rash—Hydroxyurea—brain cancer	0.000188	0.00186	CcSEcCtD
Terbinafine—Confusional state—Etoposide—brain cancer	0.000188	0.00186	CcSEcCtD
Terbinafine—Dermatitis—Hydroxyurea—brain cancer	0.000188	0.00186	CcSEcCtD
Terbinafine—Headache—Hydroxyurea—brain cancer	0.000187	0.00185	CcSEcCtD
Terbinafine—Anaphylactic shock—Etoposide—brain cancer	0.000187	0.00185	CcSEcCtD
Terbinafine—Infection—Etoposide—brain cancer	0.000185	0.00183	CcSEcCtD
Terbinafine—Urticaria—Temozolomide—brain cancer	0.000185	0.00183	CcSEcCtD
Terbinafine—Abdominal pain—Temozolomide—brain cancer	0.000184	0.00182	CcSEcCtD
Terbinafine—Body temperature increased—Temozolomide—brain cancer	0.000184	0.00182	CcSEcCtD
Terbinafine—Thrombocytopenia—Etoposide—brain cancer	0.000183	0.00181	CcSEcCtD
Terbinafine—Skin disorder—Etoposide—brain cancer	0.000181	0.00179	CcSEcCtD
Terbinafine—PTGS1—endocrine gland—brain cancer	0.000179	0.00904	CbGeAlD
Terbinafine—Anorexia—Etoposide—brain cancer	0.000178	0.00176	CcSEcCtD
Terbinafine—Hypersensitivity—Carmustine—brain cancer	0.000178	0.00176	CcSEcCtD
Terbinafine—Nausea—Hydroxyurea—brain cancer	0.000177	0.00175	CcSEcCtD
Terbinafine—PTGS1—head—brain cancer	0.000177	0.00893	CbGeAlD
Terbinafine—Asthenia—Carmustine—brain cancer	0.000173	0.00171	CcSEcCtD
Terbinafine—Hypersensitivity—Temozolomide—brain cancer	0.000172	0.0017	CcSEcCtD
Terbinafine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00017	0.00392	CbGpPWpGaD
Terbinafine—Paraesthesia—Etoposide—brain cancer	0.000168	0.00166	CcSEcCtD
Terbinafine—Asthenia—Temozolomide—brain cancer	0.000167	0.00166	CcSEcCtD
Terbinafine—Diarrhoea—Carmustine—brain cancer	0.000165	0.00163	CcSEcCtD
Terbinafine—Pruritus—Temozolomide—brain cancer	0.000165	0.00163	CcSEcCtD
Terbinafine—Decreased appetite—Etoposide—brain cancer	0.000162	0.00161	CcSEcCtD
Terbinafine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000162	0.00373	CbGpPWpGaD
Terbinafine—PTGS1—central nervous system—brain cancer	0.000161	0.00815	CbGeAlD
Terbinafine—Gastrointestinal disorder—Etoposide—brain cancer	0.000161	0.00159	CcSEcCtD
Terbinafine—Fatigue—Etoposide—brain cancer	0.000161	0.00159	CcSEcCtD
Terbinafine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00016	0.00368	CbGpPWpGaD
Terbinafine—Dizziness—Carmustine—brain cancer	0.00016	0.00158	CcSEcCtD
Terbinafine—Pain—Etoposide—brain cancer	0.00016	0.00158	CcSEcCtD
Terbinafine—Diarrhoea—Temozolomide—brain cancer	0.00016	0.00158	CcSEcCtD
Terbinafine—CYP2C8—brain—brain cancer	0.000158	0.00798	CbGeAlD
Terbinafine—Dizziness—Temozolomide—brain cancer	0.000154	0.00153	CcSEcCtD
Terbinafine—Feeling abnormal—Etoposide—brain cancer	0.000154	0.00152	CcSEcCtD
Terbinafine—Vomiting—Carmustine—brain cancer	0.000153	0.00152	CcSEcCtD
Terbinafine—Gastrointestinal pain—Etoposide—brain cancer	0.000153	0.00151	CcSEcCtD
Terbinafine—Rash—Carmustine—brain cancer	0.000152	0.00151	CcSEcCtD
Terbinafine—Dermatitis—Carmustine—brain cancer	0.000152	0.0015	CcSEcCtD
Terbinafine—Headache—Carmustine—brain cancer	0.000151	0.0015	CcSEcCtD
Terbinafine—CYP3A4—endocrine gland—brain cancer	0.000149	0.00755	CbGeAlD
Terbinafine—Vomiting—Temozolomide—brain cancer	0.000148	0.00147	CcSEcCtD
Terbinafine—Urticaria—Etoposide—brain cancer	0.000148	0.00147	CcSEcCtD
Terbinafine—Abdominal pain—Etoposide—brain cancer	0.000148	0.00146	CcSEcCtD
Terbinafine—Body temperature increased—Etoposide—brain cancer	0.000148	0.00146	CcSEcCtD
Terbinafine—Rash—Temozolomide—brain cancer	0.000147	0.00146	CcSEcCtD
Terbinafine—CYP2D6—endocrine gland—brain cancer	0.000147	0.00743	CbGeAlD
Terbinafine—Dermatitis—Temozolomide—brain cancer	0.000147	0.00145	CcSEcCtD
Terbinafine—Headache—Temozolomide—brain cancer	0.000146	0.00145	CcSEcCtD
Terbinafine—CYP2D6—head—brain cancer	0.000145	0.00734	CbGeAlD
Terbinafine—Nausea—Carmustine—brain cancer	0.000143	0.00142	CcSEcCtD
Terbinafine—SQLE—Metabolism—CYP2C9—brain cancer	0.000143	0.00329	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000139	0.00319	CbGpPWpGaD
Terbinafine—Nausea—Temozolomide—brain cancer	0.000139	0.00137	CcSEcCtD
Terbinafine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000138	0.00317	CbGpPWpGaD
Terbinafine—Hypersensitivity—Etoposide—brain cancer	0.000137	0.00136	CcSEcCtD
Terbinafine—CYP3A4—central nervous system—brain cancer	0.000135	0.00681	CbGeAlD
Terbinafine—Asthenia—Etoposide—brain cancer	0.000134	0.00132	CcSEcCtD
Terbinafine—CYP2D6—central nervous system—brain cancer	0.000132	0.0067	CbGeAlD
Terbinafine—Pruritus—Etoposide—brain cancer	0.000132	0.00131	CcSEcCtD
Terbinafine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000131	0.00303	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.00013	0.003	CbGpPWpGaD
Terbinafine—CYP2D6—cerebellum—brain cancer	0.000129	0.00655	CbGeAlD
Terbinafine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000128	0.00295	CbGpPWpGaD
Terbinafine—PTGS1—brain—brain cancer	0.000128	0.00647	CbGeAlD
Terbinafine—Diarrhoea—Etoposide—brain cancer	0.000128	0.00126	CcSEcCtD
Terbinafine—Dizziness—Etoposide—brain cancer	0.000123	0.00122	CcSEcCtD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—RELA—brain cancer	0.000123	0.00284	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—SOD2—brain cancer	0.000123	0.00284	CbGpPWpGaD
Terbinafine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000122	0.00281	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—BSG—brain cancer	0.000121	0.0028	CbGpPWpGaD
Terbinafine—Vomiting—Etoposide—brain cancer	0.000119	0.00117	CcSEcCtD
Terbinafine—Rash—Etoposide—brain cancer	0.000118	0.00116	CcSEcCtD
Terbinafine—Dermatitis—Etoposide—brain cancer	0.000118	0.00116	CcSEcCtD
Terbinafine—Headache—Etoposide—brain cancer	0.000117	0.00116	CcSEcCtD
Terbinafine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000116	0.00267	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000114	0.00264	CbGpPWpGaD
Terbinafine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000112	0.00258	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—IL2—brain cancer	0.000111	0.00256	CbGpPWpGaD
Terbinafine—Nausea—Etoposide—brain cancer	0.000111	0.0011	CcSEcCtD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.000107	0.00247	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000107	0.00246	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000105	0.00243	CbGpPWpGaD
Terbinafine—CYP2D6—brain—brain cancer	0.000105	0.00532	CbGeAlD
Terbinafine—SQLE—Metabolism—IDH1—brain cancer	0.000104	0.0024	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000101	0.00233	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000101	0.00232	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—SIRT1—brain cancer	9.88e-05	0.00228	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	9.32e-05	0.00215	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.18e-05	0.00212	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	9.04e-05	0.00208	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	8.91e-05	0.00205	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.49e-05	0.00196	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—ENO2—brain cancer	8.24e-05	0.0019	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.72e-05	0.00178	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	7.47e-05	0.00172	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—RELA—brain cancer	7.12e-05	0.00164	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.97e-05	0.00161	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.88e-05	0.00159	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.71e-05	0.00155	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CYP2C9—brain cancer	6.17e-05	0.00142	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.65e-05	0.0013	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.38e-05	0.00124	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—BSG—brain cancer	5.25e-05	0.00121	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.99e-05	0.00115	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.84e-05	0.00112	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	4.82e-05	0.00111	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	4.78e-05	0.0011	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—IDH1—brain cancer	4.51e-05	0.00104	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.45e-05	0.00103	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	4.21e-05	0.000969	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.12e-05	0.000949	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CYP2C9—brain cancer	4.09e-05	0.000942	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	3.87e-05	0.000892	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.79e-05	0.000873	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	3.78e-05	0.000872	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—PIK3CG—brain cancer	3.78e-05	0.000872	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.7e-05	0.000854	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.7e-05	0.000854	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.67e-05	0.000847	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.65e-05	0.000841	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—ENO2—brain cancer	3.57e-05	0.000822	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—BSG—brain cancer	3.47e-05	0.000801	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.47e-05	0.0008	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CYP2C9—brain cancer	3.44e-05	0.000793	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.26e-05	0.000751	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	3.18e-05	0.000732	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—IDH1—brain cancer	2.99e-05	0.000689	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.97e-05	0.000684	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—BSG—brain cancer	2.92e-05	0.000674	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.54e-05	0.000585	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—IDH1—brain cancer	2.52e-05	0.00058	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.43e-05	0.000561	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ENO2—brain cancer	2.36e-05	0.000545	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP2C9—brain cancer	2.22e-05	0.000512	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.05e-05	0.000472	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ENO2—brain cancer	1.99e-05	0.000458	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP2C9—brain cancer	1.98e-05	0.000457	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—BSG—brain cancer	1.89e-05	0.000436	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.82e-05	0.00042	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—BSG—brain cancer	1.69e-05	0.000389	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CG—brain cancer	1.64e-05	0.000377	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—IDH1—brain cancer	1.62e-05	0.000375	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—BSG—brain cancer	1.55e-05	0.000358	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.55e-05	0.000356	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—BSG—brain cancer	1.54e-05	0.000354	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—IDH1—brain cancer	1.45e-05	0.000334	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—IDH1—brain cancer	1.33e-05	0.000307	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.32e-05	0.000305	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—IDH1—brain cancer	1.32e-05	0.000305	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—BSG—brain cancer	1.31e-05	0.000303	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ENO2—brain cancer	1.28e-05	0.000296	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.19e-05	0.000275	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.18e-05	0.000272	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ENO2—brain cancer	1.15e-05	0.000264	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—IDH1—brain cancer	1.13e-05	0.00026	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CG—brain cancer	1.08e-05	0.00025	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.08e-05	0.000248	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ENO2—brain cancer	1.05e-05	0.000243	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ENO2—brain cancer	1.05e-05	0.000241	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—BSG—brain cancer	1.01e-05	0.000234	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.2e-06	0.000212	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CG—brain cancer	9.12e-06	0.00021	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ENO2—brain cancer	8.93e-06	0.000206	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—IDH1—brain cancer	8.72e-06	0.000201	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ENO2—brain cancer	6.89e-06	0.000159	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CG—brain cancer	5.89e-06	0.000136	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CG—brain cancer	5.26e-06	0.000121	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.84e-06	0.000111	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.79e-06	0.000111	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CG—brain cancer	4.1e-06	9.45e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CG—brain cancer	3.16e-06	7.29e-05	CbGpPWpGaD
